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Background
The development of chemoresistance still is a major
problem in cancer therapy. Mainly, impact of che-
motherapy is based on the upregulation of ATP-binding
cassette (ABC) transporters, which correlates with bad
prognosis and less chemotherapeutic success. Previously,
we could show that the HMG-CoA reductase inhibitor
simvastatin is able to inhibit the most prominent ABC
transporter ABCB1. Additionally, we demonstrated that
simvastatin coadministrated with the anthracycline dox-
orubicin led to increased apoptosis in neuroblastoma
cells, and that these effects were comparable with the
potential of verapamil, a first generation inhibitor of
ABCB1 [1].
Methods
The neuroblastoma cell line SH-SY5Y was used for our
analyses. Alterations in the protein level of ABC trans-
porters were demonstrated by Western blot analyses
and in more detail with FACS. RNA from SH-SY5Y
cells treated with simvastatin for 6 and 72 hours was
isolated, and the mRNA levels of various ABC transpor-
ters were quantified by real-time PCR.
Results
Simvastatin exposure led to a concentration-dependent
decrease of ABCB1. Similarly, FACS analyses demon-
strated a significant decrease of ABCB1 expression on
the cell surface. Moreover, doxorubicin-induced eleva-
tions in ABCB1 cell surface expression were reversed by
simvastatin. However, compensation of ABCB1 by other
ABC transporters like ABCC1 and ABCC4 could not be
detected. Conversely, ABCG2 showed upregulation on
protein and mRNA level.
Conclusions
Here we show that simvastatin is able to modulate ABCB1
expression. This potential seems to be divided in immedi-
ate and long-term effects. Expression of ABCB1 was
downregulated on protein as well as on mRNA level after
long-term incubation and partially compensated by other
ABC transporters. Moreover, we also observed short-term
regulation of the cell surface expression without any
changes in total cellular level which might be based on
impact of simvastatin in ABCB1 turn-over. Based on our
findings, we suggest that simvastatin is a promising candi-
date as an adjuvant chemotherapeutic drug to impair
transporter-mediated multidrug resistance.
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